spotlight. | Camford Capital

top of page

Ceribell, the developer of a novel headband designed to speed seizure detection in hospitals, goes public on Nasdaq.

Ceribell, the developer of the first AI-powered point-of-care EEG diagnostic system aimed to revolutionize seizure management in acute...

CG Oncology, the pioneering developer of bladder cancer therapeutics goes public on Nasdaq.

CG Oncology, a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone...

bottom of page